Scarica l'app Stockscreener
34.62
3.46%
-1.24
Dopo l'orario di chiusura:
34.62
Precedente Chiudi:
$35.86
Aprire:
$35.56
Volume 24 ore:
1.61M
Relative Volume:
1.34
Capitalizzazione di mercato:
$7.92B
Reddito:
$5.30B
Utile/perdita netta:
$-624.00M
Rapporto P/E:
-11.28
EPS:
-3.0692
Flusso di cassa netto:
$42.00M
1 W Prestazione:
-12.13%
1M Prestazione:
-13.54%
6M Prestazione:
-21.21%
1 anno Prestazione:
-49.15%
Intervallo 1D:
$34.22
$36.31
Intervallo di 1 settimana:
$34.22
$39.86
Portata 52W:
$34.22
$68.81
Lineage Inc Stock (LINE) Company Profile
Nome
Lineage Inc
Settore
Industria
Telefono
(800) 678-7271
Indirizzo
46500 HUMBOLDT DRIVE, NOVI
Confronta LINE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LINE
Lineage Inc
|
34.62 | 8.19B | 5.30B | -624.00M | 42.00M | -3.0692 |
|
PLD
Prologis Inc
|
125.60 | 115.18B | 8.74B | 3.43B | 4.27B | 3.4347 |
|
PSA
Public Storage
|
278.05 | 48.07B | 4.79B | 1.91B | 2.93B | 9.6238 |
|
EXR
Extra Space Storage Inc
|
133.18 | 27.82B | 3.34B | 997.83M | 1.73B | 4.4718 |
|
REXR
Rexford Industrial Realty Inc
|
41.84 | 9.52B | 903.94M | 275.97M | 94.31M | 1.23 |
|
EGP
Eastgroup Properties Inc
|
177.70 | 9.31B | 679.77M | 236.60M | 385.49M | 4.6371 |
Lineage Inc Stock (LINE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-06 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Downgrade | BofA Securities | Buy → Underperform |
| 2025-07-01 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-06-23 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-06-12 | Downgrade | BNP Paribas Exane | Neutral → Underperform |
| 2025-05-06 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-04-10 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-28 | Iniziato | Citigroup | Neutral |
| 2025-01-14 | Iniziato | Exane BNP Paribas | Neutral |
| 2024-12-20 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-09-18 | Iniziato | CapitalOne | Overweight |
| 2024-09-16 | Iniziato | CapitalOne | Overweight |
| 2024-08-19 | Iniziato | Deutsche Bank | Hold |
| 2024-08-19 | Iniziato | Evercore ISI | In-line |
| 2024-08-19 | Iniziato | Goldman | Buy |
| 2024-08-19 | Iniziato | JP Morgan | Overweight |
| 2024-08-19 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-08-19 | Iniziato | Mizuho | Neutral |
| 2024-08-19 | Iniziato | Morgan Stanley | Overweight |
| 2024-08-19 | Iniziato | Piper Sandler | Overweight |
| 2024-08-19 | Iniziato | Robert W. Baird | Outperform |
| 2024-08-19 | Iniziato | Scotiabank | Sector Outperform |
| 2024-08-19 | Iniziato | Truist | Buy |
| 2024-08-19 | Iniziato | UBS | Neutral |
| 2024-08-19 | Iniziato | Wells Fargo | Equal Weight |
Mostra tutto
Lineage Inc Borsa (LINE) Ultime notizie
What dividend safety score for Lineage Inc. stockJobs Report & High Win Rate Trade Alerts - newser.com
Will Lineage Inc. stock remain a Wall Street favoriteJuly 2025 Catalysts & High Accuracy Swing Trade Signals - newser.com
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q3 2025 Earnings Call Transcript - Insider Monkey
Lineage, Inc. (LINE) Gets a Hold from Scotiabank - The Globe and Mail
Lineage Cell Therapeutics: Progress Amid Financial Challenges - TipRanks
Lineage (NASDAQ:LINE) Sets New 1-Year Low After Analyst Downgrade - MarketBeat
Mizuho Lowers Lineage (NASDAQ:LINE) Price Target to $40.00 - MarketBeat
Cbre Investment Management Listed Real Assets LLC Reduces Stock Position in Lineage, Inc. $LINE - MarketBeat
Volume spikes in Lineage Inc. stock – what they meanJuly 2025 Summary & Scalable Portfolio Growth Methods - newser.com
Will Lineage Inc. stock benefit from upcoming earnings reportsRate Cut & Weekly Market Pulse Updates - newser.com
Lineage Inc. stock chart pattern explainedMarket Movement Recap & Free Low Drawdown Momentum Trade Ideas - newser.com
Lineage Cell Therapeutics Reports Q3 2025 Results - TipRanks
Lineage Cell Therapeutics Inc (LCTX) Q3 2025 Earnings Call Highl - GuruFocus
Lineage Cell Therapeutics Inc (LCTX) Q3 2025 Earnings Call Highlights: Strategic Partnerships ... - Yahoo Finance
Will Lineage Cell Therapeutics Inc. stock outperform international peersPortfolio Performance Report & Long-Term Growth Portfolio Plans - newser.com
Lineage Inc stock hits 52-week low at 36.55 USD By Investing.com - Investing.com South Africa
Lineage Cell Therapeutics Inc (LCTX) Q3 2025 Earnings: Revenue S - GuruFocus
Lineage Cell: Q3 Earnings Snapshot - San Francisco Chronicle
Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - Business Wire
Lineage (NASDAQ:LINE) Announces Quarterly Earnings Results, Beats Estimates By $0.07 EPS - MarketBeat
Lineage Inc stock hits 52-week low at 36.55 USD - Investing.com
Lineage stock rating downgraded by Piper Sandler on weak inventory build - Investing.com Canada
Is Lineage Cell Therapeutics Inc. stock cheap by valuation metricsJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - newser.com
What earnings revisions data tells us about Lineage Inc.CEO Change & Entry Point Strategy Guides - newser.com
How to recover losses in Lineage Inc. stock2025 Historical Comparison & Free Expert Approved Momentum Trade Ideas - newser.com
Mizuho lowers Lineage stock price target to $40 from $44 on AFFO concerns - Investing.com
Tools to assess Lineage Cell Therapeutics Inc.’s risk profileJuly 2025 Drop Watch & Intraday High Probability Alerts - newser.com
Tyson Foods sells 4 cold storage warehouses, including 1 in Pa., for $247M - MSN
Lineage (LINE) Losses Compound 47.2% Annually, Challenging Bullish Profit Turnaround Narrative - Yahoo Finance
Technical analysis overview for Lineage Inc. stock2025 AllTime Highs & Safe Capital Growth Trade Ideas - newser.com
Will Lineage Inc. stock benefit from infrastructure spendingGDP Growth & Pattern Based Trade Signal System - newser.com
Can Lineage Inc. stock sustain revenue growthJuly 2025 Fed Impact & Free Reliable Trade Execution Plans - Fundação Cultural do Pará
Lineage, Inc. Reports Q3 2025 Financial Results - TipRanks
Decoding Lineage Inc (LINE): A Strategic SWOT Insight - GuruFocus
Will Lineage Cell Therapeutics Inc. stock benefit from commodity prices2025 Trading Recap & Stock Portfolio Risk Control - newser.com
Lineage, Inc. (LINE) Tops Q3 FFO and Revenue Estimates - sharewise.com
Lineage (LINE) Losses Worsen 47.2% Annually, Testing Faith in Profit Turnaround Narrative - simplywall.st
Lineage, Inc. Reports Mixed Sentiment in Earnings Call - TipRanks
How Lineage Inc. stock benefits from global expansionJuly 2025 Setups & Low Risk Investment Opportunities - Fundação Cultural do Pará
Lineage Inc (LINE) Q3 2025 Earnings Call Highlights: Record Revenue Amid Market Challenges By GuruFocus - Investing.com Canada
Lineage outlines $319M–$334M Q4 EBITDA target as guidance shifts amid tariff headwinds - MSN
Lineage trims full-year outlook on tariff overhang - Yahoo Finance
Lineage Q3 2025 slides: revenue up 3%, guidance lowered amid market challenges - Investing.com
Earnings call transcript: Lineage Inc Q3 2025 sees revenue growth, stock dips - Investing.com
Lineage, Inc. (LINE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Earnings call transcript: Lineage Inc Q3 2025 sees revenue growth, stock dips By Investing.com - Investing.com South Africa
Lineage Inc Azioni (LINE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lineage Inc Azioni (LINE) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Thattai Sudarsan V | See Remarks |
Aug 08 '25 |
Buy |
42.45 |
3,563 |
151,238 |
7,983 |
| Marchetti Kevin Patrick | CO-EXECUTIVE CHAIRMAN |
Aug 08 '25 |
Buy |
42.28 |
23,540 |
995,216 |
62,323 |
| Marchetti Kevin Patrick | CO-EXECUTIVE CHAIRMAN |
May 09 '25 |
Buy |
45.63 |
11,050 |
504,187 |
38,783 |
| Forste Adam Matthew Schwartz | CO-EXECUTIVE CHAIRMAN |
May 08 '25 |
Buy |
44.93 |
10,949 |
491,921 |
35,266 |
| Marchetti Kevin Patrick | CO-EXECUTIVE CHAIRMAN |
May 06 '25 |
Buy |
43.75 |
11,500 |
503,074 |
27,733 |
| Thattai Sudarsan V | See Remarks |
May 05 '25 |
Buy |
45.23 |
4,420 |
199,908 |
4,420 |
| Forste Adam Matthew Schwartz | CO-EXECUTIVE CHAIRMAN |
Feb 28 '25 |
Buy |
60.50 |
24,317 |
1,471,144 |
24,317 |
| Marchetti Kevin Patrick | CO-EXECUTIVE CHAIRMAN |
Feb 28 '25 |
Buy |
60.51 |
16,233 |
982,229 |
16,233 |
2.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):